Cardiovascular Disease Doctors in South Carolina Medicare Details, Address, Contact

303 Cardiovascular Disease doctors found. Showing 301 - 303

Dr. Robert M Malanuk, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2728 Sunset Blvd Ste 300, West Columbia, SC 29169 Phone: 803-744-4940    Fax: 803-744-4938

Dr. Richard Taylor Williams, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2728 Sunset Blvd Ste 300, West Columbia, SC 29169 Phone: 803-744-4940    Fax: 803-744-4938

Dr. Mitchell Wells Jacocks, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2728 Sunset Blvd Ste 300, West Columbia, SC 29169 Phone: 803-744-4940    Fax: 803-744-4938

News Archive

Cancer-fighting protein successfully placed directly into solid tumors and turned on

Experiments at the Pioneer Valley Life Sciences Institute (PVLSI) at Baystate Medical Center in Springfield, Mass., reported in a recent British Journal of Cancer, confirm that University of Massachusetts Amherst chemical engineer Neil Forbes' delivery and trigger system has for the first time successfully placed TRAIL, a cancer-fighting protein, directly into solid tumors and on cue, turned it on. The treatment improved the 30-day survival time of mice with mammary tumors from 0 to 100 percent.

Suneva Medical publishes Artefill data for treatment of atrophic acne scars

Suneva Medical, a privately-held aesthetic medical device company, today announced the publication of an open-label, single center, pilot study on Artefill for the treatment of atrophic acne scars conducted by James M. Spencer, M.D. M.S. and sponsored by Suneva Medical.

Study examines link between gestational age at birth and mortality in young adulthood

In a study that included more than 600,000 individuals born in Sweden between 1973-1979, those born preterm had a higher risk of death during early childhood and young adulthood than persons born at term, according to a study in the September 21 issue of JAMA.

Helix completes GLP toxicology study milestone in L-DOS47 development program

Helix BioPharma Corp. today announced that it has completed its definitive GLP, rodent and primate, repeat-dose toxicology studies with L-DOS47. These studies demonstrated a good safety profile in an expanded number of rodent and primate test animals, building upon Helix's positive findings from its preliminary non-GLP toxicology studies.

Read more Medical News

› Verified 5 days ago

• «
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16(current)